Arkolith/Insider Trading/ATXS/Form 4

Milne Jill C.

CEO and President, DirectorAstria Therapeutics, Inc. (ATXS) · full profile →Form 4 · filed Jan 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 23, 2026Disposed to issuer(D)4K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 23, 2026Disposed to issuer(D)761K——0
Jan 23, 2026Disposed to issuer(D)195K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-000322) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML